Efficacy of 12-week treatment with polyethylene glycol loxenatide in obesity or overweight patients with type 2 diabetes: a multicenter, prospective cohort study based on the flash glucose monitoring system.

Saved in:
Bibliographic Details
Title: Efficacy of 12-week treatment with polyethylene glycol loxenatide in obesity or overweight patients with type 2 diabetes: a multicenter, prospective cohort study based on the flash glucose monitoring system.
Authors: Zhu L; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.; Department of Endocrinology, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, China., Li H; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.; Department of Endocrinology, Nanjing Lishui People's Hospital, Zhongda Hospital Lishui Branch, Southeast University, Nanjing, China., Zhang Y; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China., Tao S; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China., Yan R; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China., Luo Y; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China., Shen Z; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China., Li H; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China., Kong X; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China., Ma J; Department of Endocrinology, Nanjing First Hospital, Nanjing Medical University, Nanjing, China.
Source: Frontiers in endocrinology [Front Endocrinol (Lausanne)] 2026 May 19; Vol. 17, pp. 1810786. Date of Electronic Publication: 2026 May 19 (Print Publication: 2026).
Publication Type: Journal Article; Multicenter Study; Clinical Trial
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101555782 Publication Model: eCollection Cited Medium: Print ISSN: 1664-2392 (Print) Linking ISSN: 16642392 NLM ISO Abbreviation: Front Endocrinol (Lausanne) Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-2392
DOI:10.3389/fendo.2026.1810786